Acucela gets EMA approval for Emixustat to treat Stargardt disease

Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharm...

June 11, 2019 | Tuesday | News
Sosei Heptares to receive new $3 million milestone payment from Pfizer

Sosei Group Corporation and its strategic alliance partner Pfizer announce that a new clinical candidate from their mult...

June 10, 2019 | Monday | News
CStone and Bayer to evaluate PD-L1 monoclonal antibody CS1001 in combination with regorafenib

CStone Pharmaceuticals, on 9 June 2019, announced its global clinical collaboration with China focus with Baye...

June 10, 2019 | Monday | News
Luye Pharma's Rykindo gets NDA filing acceptance by USFDA

Rykindo® (LY03004), Luye Pharma's innovative, independently developed Extended-Release Microspheres f...

May 30, 2019 | Thursday | News
Sihuan Pharm achieves new grant approval

Sihuan Pharmaceutical Holdings Group Ltd., the largest cardio-cerebral vascular (CCV) drug manufacturer in China's&...

May 28, 2019 | Tuesday | News
BGU introduces Novel Combination Therapy for treating neurological disorders

BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), introduces a novel drug comb...

May 13, 2019 | Monday | News
Taiwan Health Ministry approves Vemlidy for chronic hepatitis B

Gilead Sciences, Inc. has recently announced that with effect from 1 May 2019, Vemlidy (tenofovir alafenamide, TAF)...

April 30, 2019 | Tuesday | News
ADC Therapeutics and Adagene announce discovery collaboration agreement

ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of proprietary ...

April 25, 2019 | Thursday | News
Roche launches Emicizumab in India

Roche has declared  that Emicizumab (Hemlibra®) has been approved in India for Hemophilia A with factor VIII in...

April 21, 2019 | Sunday | News
Japan grants Sakigake designation to Eisai’s novel FGFR

Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. The co...

April 8, 2019 | Monday | News
Takeda takes step towards EU Entyvio extension

Takeda Pharmaceutical Company Limited announced that the European Medicines Agency (EMA) has accepted a Marketing Author...

April 2, 2019 | Tuesday | News
Standigm raises $11.5M in Series B Round

Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, announced it has r...

April 2, 2019 | Tuesday | News
Takeda, StrideBio to advance novel gene therapies for neuro diseases

StrideBio, Inc, a leading developer of novel adeno-associated viral (AAV) based gene therapies, recently announced the s...

April 1, 2019 | Monday | News
HitGen, Almirall to identify novel drug targets

HitGen has announced that the company has entered into a research collaboration with Almirall to identify novel small mo...

March 26, 2019 | Tuesday | News
BioInvent developes Anti-TNFR2 programme for cancer treatment

BioInvent International AB, focused on the discovery and development of novel and first-in-class immuno-regulatory antib...

March 21, 2019 | Thursday | News
EC approves Roche’s MabThera for a rare autoimmune disease

Roche announced that the European Commission has approved MabThera® (rituximab) for the treatment of adults with mod...

March 19, 2019 | Tuesday | News
Ono Pharma, twoXAR announce drug discovery research collaboration

Ono Pharmaceutical Co., Ltd., a Japanese pharmaceutical research and development company, and twoXAR, Inc., a US based a...

March 19, 2019 | Tuesday | News
Janssen seeks USFDA nod for Darzalex to treat ASCT multiple myeloma

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a supplemental Biologics Licen...

March 14, 2019 | Thursday | News